logo

Analyst Comments: Georgia Gulf, Brightpoint, Arena Pharma
By: Zacks Investment Research   Thursday, August 07, 2008 11:00 AM

Vote for next session
The next market session will close:

Georgia Gulf's Chasm of Debt

Georgia Gulf Corp. (GGC) recorded a net income of $27.9 million or $0.80 per diluted share, compared to a net income of $4.2 million or $0.12 per diluted share during the comparable quarter in 2007.

The company overpaid for Royal Plastics, an acquisition that was entirely financed with debt, and the company is in danger of violating debt covenants. The remaining product lines of the company are suffering from over capacity. GGC is expected to report losses in the near term on the back of rising feedstock and energy costs.

Demand for the company's products is also expected to remain weak due to the downturn in the U.S. housing and auto markets. Moreover, the company may need to sell its assets to comply with the debt covenants. As a result, we have a Sell rating with a target of $2.00.

The PVC and phenol business segments are under pressure due to capacity increases. GGC saw high production cost due to volatile energy prices. The company was unable to recover costs by increasing prices of its products. Prices for Natural gas (the key input) are increasing which is negating the impact of product price increases. This has compressed margins for the company.

Natural gas prices are expected to rise, stemming from strong US consumption, low inventory, and limited drilling activity. Georgia Gulf's end markets are primarily housing related. Until housing market conditions improve, it will be difficult for Georgia Gulf to grow profitability and reduce debt.

On July 15, Georgia Gulf will pay $2.9 million to dismiss a case brought by Sandelman Partners LP, which claimed Georgia Gulf defaulted on some of its debt.

Brightpoint Target Dimmed a Bit

Brightpoint, Inc. (CELL), a leading distributor of devices and logistic services to the wireless industry, is being challenged with global economic weakness. Second quarter fiscal 2008 financial results were significantly below our estimates.

The company's revenue growth was restricted due to softening demand in its wireless markets. Net earnings fell as a result of soaring operating costs from two recently concluded acquisitions and charges related to slow moving inventory or inventory obsolescence. Looking forward, we expect that overall macro-economic conditions may limit earnings improvements. Brightpoint's low operating margin level may also limit investments in new business endeavors.

However, ongoing restructuring activities and new contract wins have the potential to improve the financial performance over a longer time-horizon. We maintain our Hold rating with a reduced valuation target anticipating further challenges in a tight market environment.


Next Page >>12

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Zacks Investment Research



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia